OPTUS Pharmaceutical Co., Ltd. (KOSDAQ: 131030)

OPTUS Pharmaceutical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	78,804	72,426	58,658	57,316	60,827	60,441
Other Revenue	-0	-0	-	-	-	-
Revenue	78,804	72,426	58,658	57,316	60,827	60,441
Revenue Growth (YoY)	17.44%	23.47%	2.34%	-5.77%	0.64%	21.80%
Cost of Revenue	35,703	31,072	27,041	24,821	22,531	23,547
Gross Profit	43,101	41,354	31,617	32,495	38,296	36,894
Selling, General & Admin	32,410	30,623	24,138	20,589	21,588	20,212
Research & Development	1,960	1,384	1,343	1,110	821.84	1,148
Other Operating Expenses	220.17	164.19	184.49	110.92	107.83	82.82
Operating Expenses	35,710	33,168	26,368	22,023	23,489	21,705
Operating Income	7,391	8,187	5,249	10,472	14,808	15,189
Interest Expense	-104.75	-124.4	-85.89	-8.88	-17.61	-3.95
Interest & Investment Income	2,466	2,296	1,401	846.43	1,137	1,348
Currency Exchange Gain (Loss)	-2.06	3.33	12.17	127.54	-17.39	0.32
Other Non Operating Income (Expenses)	0.44	11.79	21.69	-36.76	105.62	-417.62
EBT Excluding Unusual Items	9,751	10,374	6,598	11,400	16,015	16,116
Gain (Loss) on Sale of Investments	865.34	1,967	73.39	-	2,505	364.96
Gain (Loss) on Sale of Assets	729.42	629.3	878.29	44.24	-18.97	-59.69
Asset Writedown	-	-	-721.2	-964.98	-	-
Pretax Income	11,346	12,970	6,828	10,479	18,502	16,421
Income Tax Expense	1,833	2,210	1,816	587.88	4,097	1,825
Net Income	9,513	10,760	5,012	9,892	14,405	14,596
Net Income to Common	9,513	10,760	5,012	9,892	14,405	14,596
Net Income Growth	18.86%	114.69%	-49.33%	-31.33%	-1.31%	45.92%
Shares Outstanding (Basic)	15	15	16	16	16	16
Shares Outstanding (Diluted)	15	15	16	16	16	16
Shares Change (YoY)	0.16%	-4.22%	-1.07%	-0.62%	-1.20%	0.05%
EPS (Basic)	623.09	708.35	316.00	617.00	893.00	894.00
EPS (Diluted)	623.09	708.35	316.00	617.00	893.00	894.00
EPS Growth	18.68%	124.16%	-48.78%	-30.91%	-0.11%	45.84%
Free Cash Flow	-134.44	9,109	-3,955	-3,557	11,603	13,025
Free Cash Flow Per Share	-8.80	599.63	-249.37	-221.86	719.32	797.76
Gross Margin	54.69%	57.10%	53.90%	56.69%	62.96%	61.04%
Operating Margin	9.38%	11.30%	8.95%	18.27%	24.34%	25.13%
Profit Margin	12.07%	14.86%	8.54%	17.26%	23.68%	24.15%
Free Cash Flow Margin	-0.17%	12.58%	-6.74%	-6.21%	19.08%	21.55%
EBITDA	11,366	12,424	8,712	12,895	17,392	17,809
EBITDA Margin	14.42%	17.15%	14.85%	22.50%	28.59%	29.46%
D&A For EBITDA	3,975	4,238	3,463	2,423	2,585	2,620
EBIT	7,391	8,187	5,249	10,472	14,808	15,189
EBIT Margin	9.38%	11.30%	8.95%	18.27%	24.34%	25.13%
Effective Tax Rate	16.15%	17.04%	26.60%	5.61%	22.14%	11.11%
Advertising Expenses	-	1,515	364.81	100.36	70.72	130.21

Source: S&P Capital IQ. Standard template. Financial Sources.